Biopharma company Corcept Therapeutics (NASDAQ:CORT) will be announcing earnings results this Tuesday afternoon. Here’s what to expect. Corcept missed analysts’ revenue expectations last quarter, ...

Get the detailed quarterly/annual income statement for Corcept Therapeutics Incorporated (CORT). Find out the revenue, expenses and profit or loss over the last fiscal year.

A high-level overview of Corcept Therapeutics Incorporated (CORT) stock. View (CORT) real-time stock price, chart, news, analysis, analyst reviews and more.

Get the latest news and real-time alerts from Corcept Therapeutics Incorporated (CORT) stock at Seeking Alpha.

ST. LOUIS—A former congressional candidate who until recently was an assistant U.S. Attorney for the Eastern District of Missouri is St. Louis County Executive Sam Page’s choice to become the next ...

Corcept Therapeutics Inc. Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications ...

How we use your information depends on the product and service that you use and your relationship with us. We may use it to: Verify your identity, personalize the content you receive, or create and ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 p.m. to 4 a.m. ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...